Insulin-Like Growth Factor-I Activates Gene Transcription Programs Strongly Associated With Poor Breast Cancer PrognosisChad J. Creighton, Adrian V. Lee, Angelo Casà et al.|Journal of Clinical Oncology|2008Cited by 261
Proteomic and transcriptomic profiling reveals a link between the PI3K pathway and lower estrogen-receptor (ER) levels and activity in ER+ breast cancerChad J. Creighton, Rachel Schiff, Xiaoyong Fu et al.|Breast Cancer Research|2010Cited by 258
High IGF-IR Activity in Triple-Negative Breast Cancer Cell Lines and Tumorgrafts Correlates with Sensitivity to Anti–IGF-IR TherapyBeate C. Litzenburger, Adrian V. Lee, Susan G. Hilsenbeck et al.|Clinical Cancer Research|2010Cited by 131
Molecular profiles of progesterone receptor loss in human breast tumorsChad J. Creighton, Rachel Schiff, C. Kent Osborne et al.|Breast Cancer Research and Treatment|2008Cited by 126
Overcoming endocrine resistance due to reduced PTEN levels in estrogen receptor-positive breast cancer by co-targeting mammalian target of rapamycin, protein kinase B, or mitogen-activated protein kinase kinaseXiaoyong Fu, Rachel Schiff, Chad J. Creighton et al.|Breast Cancer Research|2014Cited by 70